The prognostic value of response to the first cycle of chemotherapy in small cell lung cancer. Results of a multicenter German trial
- 1 August 1987
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 23 (8) , 1197-1205
- https://doi.org/10.1016/0277-5379(87)90155-6
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Combination chemotherapy with adriamycin, etoposide, and cyclophosphamide for small cell carcinoma of the lung. A study by the EORTC lung cancer working party (Belgium)Cancer, 1985
- Randomized trial of radiotherapy to the thorax in limited small-cell carcinoma of the lung treated with multiagent chemotherapy and elective brain irradiation: a preliminary report.Journal of Clinical Oncology, 1984
- Combined modality treatment of extensive small cell lung cancer: a Southwest Oncology Group study.Journal of Clinical Oncology, 1984
- Combined modality induction therapy without maintenance chemotherapy for small cell carcinoma of the lung.Journal of Clinical Oncology, 1984
- Comparing survival of responders and nonresponders after treatment: A potential source of confusion in interpreting cancer clinical trialsControlled Clinical Trials, 1983
- Cisplatin, adriamycin, and etoposide (cav) for remission induction of small-cell bronchogenic carcinoma. Evaluation of efficacy and toxicity and pilot study of a “late intensification” with autologous bone-marrow rescueCancer, 1982
- Alternating non-cross-resistant combination chemotherapy for small cell anaplastic carcinoma of the lungCancer, 1982
- Combination chemotherapy, radiotherapy, and BCG immunotherapy in limited small-cell carcinoma of the lung: A Southwest Oncology group studyCancer, 1982
- Evaluation of response criteria in advanced lung cancerCancer, 1979